Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Whittier Trust Co.

Whittier Trust Co. decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 52.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,185 shares of the pharmacy operator’s stock after selling 3,486 shares during the quarter. Whittier Trust Co.’s holdings in Walgreens Boots Alliance were worth $29,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in WBA. Iron Horse Wealth Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 1,300 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 1,081 shares during the last quarter. Continuum Advisory LLC boosted its holdings in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,020 shares during the last quarter. Strategic Investment Solutions Inc. IL acquired a new position in Walgreens Boots Alliance in the second quarter valued at $34,000. Finally, New Covenant Trust Company N.A. acquired a new position in Walgreens Boots Alliance in the first quarter valued at $35,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.1 %

Shares of NASDAQ WBA opened at $9.34 on Friday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.22 and a 1 year high of $27.05. The firm has a market cap of $8.08 billion, a price-to-earnings ratio of -0.93, a PEG ratio of 1.24 and a beta of 0.70. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The stock’s 50-day simple moving average is $9.37 and its 200-day simple moving average is $12.91.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period in the previous year, the company earned $0.67 earnings per share. The company’s revenue for the quarter was up 5.9% compared to the same quarter last year. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.57 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.71%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on WBA shares. TD Cowen reduced their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday. Barclays lifted their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Jefferies Financial Group reduced their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday. Bank of America reduced their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. Finally, Royal Bank of Canada reduced their target price on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 2nd. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.